4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-21-043137
Chief Commercial Officer sold 3,625 shares at $89.22 ($323,423)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hassard James Chief Commercial Officer | 2021-06-22 | Sale | −3,625 | $89.22 | $323,423 | 105,750 | D: show line 1 in the form |
| Open-market sales · 3,625 sh · avg $89.22 · $323,423 | |||||||
Loading xslF345X03/doc4.xml…